The Ups and Downs of Living With HBV: Conversations Between Patient and Physician #4
Episode 4 of this series features a conversation between a patient, Jason, and Paul Y. Kwo, MD, who discuss the particular challenges that can affect people with chronic hepatitis B seeking care in ru...
25 Maalis 202218min
Key Decisions in HIV Care: PrEP Considerations in Cisgender Men and Transgender Women
In this episode from the series “Key Decisions in HIV Care,” Latesha Elopre, MD, MSPH, and Karine Lacombe, MD, PhD, discuss important considerations for PrEP in cisgender men and transgender women, in...
25 Maalis 202231min
Key Decisions in HIV Care: PrEP Considerations in Cisgender Women
In this episode from the series “Key Decisions in HIV Care,” Latesha Elopre, MD, MSPH, and Karine Lacombe, MD, PhD, discuss important considerations for PrEP in cisgender women, including: Discussion ...
24 Maalis 202238min
Lessons From Lockdown: HCC and Liver Transplant Care in the COVID-19 Era
In this episode, Graham R. Foster, FRCP, PhD, and Paul Y. Kwo, MD, share lessons learned in the management of HCC and liver transplantation the COVID-19 era, including:• Global impact of HCC and strat...
23 Maalis 202229min
Key Decisions in HIV Care: Considerations for Long-Acting Injectable PrEP
In this episode, Jason Schafer, PharmD, MPH, explores key considerations for the use of long-acting injectable pre-exposure prophylaxis (PrEP).- Listen as he gives his perspectives on:- The FDA approv...
21 Maalis 202213min
Rational Use of New and Emerging Agents for Hepatitis Delta Virus
Hepatitis delta virus (HDV) is the most severe form of viral hepatitis and warrants new treatment options for better efficacy and tolerability. In part 2 of this 2-part podcast series, hear Heiner Wed...
16 Maalis 202221min
Conference Conversations: HIV Advanced Practice Provider Perspectives from CROI 2022
In this episode, Jeffrey Kwong, DNP, MPH, FAANP, FAAN, and Susan LeLacheur, DrPH, PA-C, AAHIVS, share insights on new HIV data from CROI 2022, including:Perinatal antiretroviral therapy exposureInvest...
16 Maalis 202218min
HABP/VABP and Gram-Negative Resistance: Pathways to Early Effective Therapy
In this episode, Keith S. Kaye, MD, MPH; Lilian Abbo, MD, FIDSA; and Jason M. Pogue, PharmD, discuss HABP/VABP and gram-negative resistance including:Epidemiology and burden of nosocomial bacterial pn...
15 Maalis 20221h 41min
